Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 89.82B | 86.02B | 93.08B | 122.17B | 112.35B |
Gross Profit | 89.82B | 87.15B | 93.08B | 122.17B | 112.35B |
EBITDA | 10.41B | 9.21B | 6.58B | 10.38B | 6.53B |
Net Income | 7.89B | 7.19B | 6.67B | 7.29B | 3.16B |
Balance Sheet | |||||
Total Assets | 653.80B | 644.45B | 696.70B | 775.49B | 804.59B |
Cash, Cash Equivalents and Short-Term Investments | 333.57B | 320.12B | 323.68B | 25.05B | 28.24B |
Total Debt | 62.14B | 59.54B | 63.75B | 57.22B | 59.64B |
Total Liabilities | 601.40B | 592.05B | 648.32B | 692.51B | 719.19B |
Stockholders Equity | 49.90B | 44.14B | 45.35B | 71.14B | 71.61B |
Cash Flow | |||||
Free Cash Flow | 11.99B | 5.16B | 7.53B | 6.18B | 25.14B |
Operating Cash Flow | 11.57B | 5.59B | 7.88B | 6.53B | 25.53B |
Investing Cash Flow | -11.25B | -1.60B | 470.00M | -8.95B | -11.43B |
Financing Cash Flow | -7.33B | -5.93B | -6.12B | -4.33B | -4.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €92.13B | 11.97 | 15.98% | 5.09% | 6.79% | 11.81% | |
68 Neutral | $17.10B | 11.44 | 9.70% | 3.58% | 11.11% | -4.78% | |
― | €14.70B | 11.22 | 11.17% | 5.94% | ― | ― | |
― | €88.65B | 8.22 | 9.58% | 6.09% | ― | ― | |
― | €48.43B | 7.63 | 9.68% | 6.84% | ― | ― | |
― | €5.40B | 647.83 | 0.17% | 0.27% | ― | ― | |
― | €34.79B | 11.42 | 5.93% | 3.63% | ― | ― |
AXA SA has announced the details of its upcoming Combined General Meeting for shareholders, scheduled for April 24, 2025, in Paris. The meeting will cover ordinary and extraordinary matters, with relevant documents available on AXA’s website. This event is significant for stakeholders as it provides insights into the company’s strategic direction and governance, reinforcing AXA’s transparency and engagement with its investors.